Effect of Age and Level of Education on Neurocognitive Impairment in HIV Positive Zambian Adults by Kabuba, Norma Namasiku Zewelanji et al.
Effect of Age and Level of Education on Neurocognitive Impairment in
HIV Positive Zambian Adults
Norma Kabuba
University of Zambia and Norwegian University of Science and
Technology
J. Anitha Menon
University of Zambia
Donald R. Franklin Jr.
University of California, San Diego
Stian Lydersen
Norwegian University of Science and Technology
Robert K. Heaton
University of California, San Diego
Knut A. Hestad
Innlandet Hospital Trust, Hamar, Norway, and Hedmark
University of Applied Sciences
Objective: Older age and lower education levels are known to be associated with worse neurocognitive (NC)
performance in healthy adults, and individuals with HIV infection may experience accelerated brain/cognition
aging. However, higher education may possibly protect against HIV-associated neurocognitive disorders
(HAND). The aim of the current cross-sectional study was to assess the effect of age and education in an
HIV-1 clade C infected adult population in urban Zambia. Method: Demographically corrected Zambian
norms on a neuropsychological (NP) test battery were used to correct for normal age and education effects.
The study assessed 286 HIV positive () males (37.1%) and females (62.9%) with a mean age of 41.35 (SD
8.56) and mean years of education 10.16 (SD 2.18). A comprehensive NP test battery was used to assess
cognitive domains frequently affected by HIV: attention/working memory, learning/and delayed recall,
executive function, verbal fluency, processing speed, verbal and visual episodic memory, and fine motor skills.
Results: In younger HIV Zambians, higher education evidenced protective effects against NC impairments
overall, and for the specific domains of executive functions, learning and speed of information processing.
Impairment scores did not support accelerated overall brain aging although the restricted age range and relative
youth of our total sample may have precluded detection of such tendencies. Conclusions: The present study
raises the need to investigate factors that could be implicated in the poor neurocognitive performance among
the younger, less educated HIV individuals in Zambia.
General Scientific Summary
Zambia’s younger, less educated HIV individuals are at risk for cognitive impairment. Age and
education interaction on cognitive performance was investigated in an HIV sample in Zambia.
Younger, less educated HIV should be empowered in disease management in Zambia.
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Antiretroviral therapy (ART) has reduced the worldwide HIV
and AIDS- related mortality rates from a peak of 2.2 million in the
mid-2000s to 1.8 million in 2010 and 1.1 million in 2015 (Negin,
Mills, & Bärnighausen, 2012; UNAIDS, 2016). ART also has
helped with a reduction in the prevalence of HIV-related dementia
by as much as 50% (Bocia˛ga-Jasik, Lickiewicz, Cies´la, Mach, &
Garlicki, 2010; Cholewin´ska & Szyman´ska, 2009; Rosca, Rosca,
Simu, & Chirileanu, 2012; Vance, Fazeli, Ross, Wadley, & Ball,
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2012). On the contrary, mild to moderate NP impairments have not
declined; in fact, their prevalence actually may increase as people
are living longer with HIV and its treatment (Heaton et al., 2010).
It has also been reported that the demographics of the HIV
epidemic are steadily changing with increased proportions of
middle-aged and older adults of 50 years or older living with the
HIV infection (Gebo, 2008; Hardy & Vance, 2009; Justice, 2010).
Globally, around 2.8 million adults aged 50 years and older were
living with HIV in 2005. The United Nations General Assembly
Special Session has noticed that the burden of HIV among those
aged 50 years is frequently ignored and this represents a signif-
icant blind spot in the global response to the epidemic of HIV
infection (Negin & Cumming, 2010).
Sub-Saharan Africa is also undergoing a demographic shift in
terms of the number and age range of people living with HIV and
AIDS: Various studies report that since more people have access to
ART, mortality rates have begun to drop and HIV-positive people
are surviving much longer. The successful scale up of ART in
developing countries has moved from negligible levels in 2003 to
more than 7.9 million in 2012 (Floyd et al., 2012; Negin &
Cumming, 2010; Negin, Mills, & Bärnighausen, 2012; Reniers et
al., 2009).
Since its first reported incidence of HIV in the 1980s, Zambia,
a sub-Saharan African country, has been making strides to allevi-
ate the effects of HIV and AIDS on its population. To that end, the
Zambian government introduced ART free of charge at the two
major hospitals since 2002. Free ART is currently offered at
various primary health care centers and all government clinics in
Zambia (Stringer et al., 2006).
However, as increasingly more people infected with HIV live
longer, it is postulated that there will be a corresponding increase
in milder forms of HAND. These forms have been named asymp-
tomatic neurocognitive impairment, and mild neurocognitive dis-
orders, which, according to some estimates, are affecting 30–60%
of people living with HIV (Cholewin´ska & Szyman´ska, 2009;
Heaton et al., 2010; Vance et al., 2012).
The aforementioned HIV-associated neurocognitive disorders
affect various aspects of cognitive functioning including impair-
ments in attention, concentration, learning, memory, psychomotor
ability and speed of information processing (Kabuba, Menon,
Franklin, Heaton, & Hestad, 2017; Negin & Cumming, 2010).
It is well documented that increasing age in itself is associated
with declines in cognitive functioning. Equally, HIV infection is
also associated with a risk of cognitive decline. Therefore, with the
steady increase in the number of older adults living with HIV,
there is need to understand the interaction of age and HIV-1
associated cognitive impairment (Hardy & Vance, 2009; Kissel,
Pukay-Martin, & Bornstein, 2005; Valcour et al., 2004; Vance,
2009; Vance, McDougall, Wilson, Debiasi, & Cody, 2014).
The combined risks of HIV infection and older age are reported
to increase the prevalence or severity of impairment beyond effects
of either risk alone (Milanini & Valcour, 2017; Saylor et al., 2016).
Previous studies have revealed that older HIV individuals are
more likely to develop cognitive problems and a decline in func-
tional ability (Farooqui & Farooqui, 2009; Sheppard et al., 2015).
Neurocognitive impairment within HIV is said to significantly
correlate with older age (Sheppard et al., 2015). Some scholars
have postulated that this could be more directly related to ART
toxicities and not HIV, however, comparative studies between
drug-conservative groups and those on aggressive treatment dem-
onstrates that uncontrolled HIV is essentially more detrimental
than ART toxicities (Deeks & Phillips, 2009; Pathai, Bajillan,
Landay, & High, 2014).
Additionally, concerns have been raised to the effect that HIV
may precipitate an NP process similar to that observed in Alzhei-
mer’s disease (Iudicello et al., 2012; Kuhlmann, Minihane,
Huebbe, Nebel, & Rimbach, 2010; Valcour et al., 2004). This
evidence thus further potentially poses an increased risk of devel-
oping cognitive problems for the older HIV individuals.
All these factors make it imperative to understand the increased
risk of HIV infection and older age especially in sub-Saharan
Africa were the number of people aging with HIV is increasing
(Joska et al., 2011, 2012; Negin & Cumming, 2010).
Another key component related to cognitive functioning and
HIV infection is education. There are currently conflicting results
regarding aspects of education that are implicated in cognitive
functioning in HIV-infected persons. Some studies involving
HIV-1 positive subjects suggest that although educational attain-
ment is an important factor in cognitive performance, years of
education does not necessarily account for quality of education
(Ryan et al., 2005). On the contrary, other studies have shown that
level of education itself has an effect on cognitive functioning in
infected groups (De Ronchi et al., 2002; Satz et al., 1993).
It is well established that level of education is an important
element not only in normal people, but also in those with brain
damage, affecting cognitive performance in various domains, es-
pecially for verbal performance tests. Higher education groups
have been reported to present slower cognitive decline as a result
of normal aging than the individuals with lower educational levels.
This is because education may have a protective effect on cogni-
tive functioning. Increased cognitive capacity, referred to as cog-
nitive reserve, is typically used to explain the delay in cognitive
and functional expression of neurodegenerative illnesses such as HIV
(Ardila, 1998; Ardila, Ostrosky-Solis, Rosselli, & Gómez, 2000;
Bornstein & Suga, 1988; Le Carret et al., 2003; Lezak, 1995;
Ostrosky-Solis, Ardila, Rosselli, Lopez-Arango, & Uriel-Mendoza,
1998; Stern, 2002; Tombaugh, 2004; Welch, Doineau, Johnson, &
King, 1996).
In normal populations, there are significant differences in cog-
nitive functioning associated with levels of education. The effect
of education is not linear but rather represents a negatively accel-
erated curve which tends to plateau. This is because the ceiling in
NP tests are typically low (Ardila, 1998).
To determine the combined effects of HIV serostatus and edu-
cation level on cognitive abnormalities, Satz et al. (1993), em-
ployed five NP tests (grooved pegboard, verbal fluency, symbol
digit modalities, and Rey auditory verbal learning). There were
abnormalities (38%) in those with less than 12 years of education
compared with 17% cognitive abnormalities that were found in
those with more than 12 years of education. They report that the
interaction between education level and serostatus was evident
even after possible confounding factors such as age, ethnicity and
CD4 count level were controlled for. Their study had the strength
of comprising a large sample size of 888 HIV and 855 HIV
participants. These results point to the potential interaction be-
tween level of education and HIV status on cognitive function.
In Zambia, the formal education system is broadly structured as
basic education (1–9 years of education) and higher education
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(10–12 years of education). Basic education is a three- tiered
system with lower basic (1–4 years), middle basic (5–7 years), and
upper basic (8–9). The first two tiers are primary education while
upper basic (8–9 years) is the first phase of secondary education
and this is followed by high education (10–12 years). Students
who complete 12 years of education are thereafter expected to
pursue tertiary education offered in colleges and universities
(UNESCO, 2011).
According to the Zambia National Education Profile (2014), the
net enrollment rate for primary school is at 94% and the primary
completion rate is 91%. The enrollment rate for lower secondary
education rate is 68% while the transition rate to higher education
is 56%.
In light of the foregoing, the current study sought to investigate
whether age and education has an effect on the cognitive function-
ing of the HIV adult population in Zambia. The current study
had the strength of employing a comprehensive NP test battery
measuring seven cognitive domains. Normal effects of age and
education were corrected for using a previously collected large
sample of healthy HIV adult Zambians (Hestad et al., 2016).
The main aim of the current study was to establish how neuro-
cognitive functioning is affected by age and level of education in
people infected with HIV-1 clade C. Specifically, we wanted to
find out the possible neurocognitive differences between HIV
young adults and HIV older adults. Furthermore, the study
sought to determine if there are neurocognitive differences be-
tween HIV participants with more years of formal education
versus those with fewer years of formal education.
We hypothesized that there would be a main effect for age and
education on NP performance in our HIV sample. We expect
that the older HIV participants will have poorer results on
demographically corrected NP test scores (from published norms),
compared with the younger HIV participants and, furthermore,
we expect that the HIV participants with higher levels of edu-
cation would have better scores than the HIV participants who
had lower levels of education.
Method
Participants
The sample was drawn from six urban clinics in the Zambian
capital city of Lusaka. The clinics sampled were; Chilenje,
Chipata, Kabwata, Kalingalinga, Matero Main, and Matero Refer-
ral clinic. All of the clinics sampled are under the management of
the Lusaka District Health Management Team in Zambia. These
clinics were chosen because of the presence of the antiretroviral
centers, which routinely provides HIV counseling and testing
services as well as providing treatment.
Participants were eligible to participate in the study if they were:
HIV sero-positive and on antiretroviral treatment. Information
about HIV status was based on the participants’ medical files.
They also were required to have a minimum of 5 years of formal
education. English is the primary language of instruction in the
Zambian school system, and the testing was performed in English
(Hestad et al., 2016). Participants were also required to be between
20 and 65 years of age (to conform to the age range of the HIV
controls who participated in the Zambian NP norming study;
Hestad et al., 2016).
Potential participants were excluded from the study if they had
a history of non-HIV related neurological disorders such as epi-
lepsy or closed head injury. This information was obtained by
means of the Neurobehavioural Medical Screen Form, which as-
sesses past medical and neurological histories (Kabuba et al.,
2017). Participants with a history of drug abuse were also excluded
from the study. This information was obtained using a structured
interview (Heaton, Miller, Taylor, & Grant, 2004; Kabuba,
Menon, & Hestad, 2011). Furthermore, Individuals with obvious
physical disabilities were excluded from the study to minimize the
possibility of test performance requiring motor dexterity being
impaired due to the handicap.
The target sample size was 324 participants, but only 286 HIV
participants were included in the current study because 38 partic-
ipants with pulmonary tuberculosis were excluded due to the
possible effect of tuberculosis on NP functioning (Robertson,
Liner, & Heaton, 2009).
Procedure
The recruitment process was carried out with the assistance of
nurses at each clinic who identified participants who routinely seek
ART meeting the inclusion criteria. Once informed consent was
obtained, the participants were referred to one of 10 neuropsychol-
ogy master of science students from University of Zambia, who
had received extensive training in interviewing, as well as admin-
istration and scoring of the NP tests. The testing process for each
participant took approximately 2 hr 30 min (Kabuba et al., 2017).
The first part of the testing process involved obtaining the
participants’ demographic characteristics, medical, and psychiatric
information based on self-report. Medical details were confirmed
by the patients’ medical records provided by the medical person-
nel. Administration of NP tests was carried out in the same order
for all participants, and they were compensated the Zambian
Kwacha equivalent of $5 (USD) for transport and refreshment
allowance at the end of the testing process (Kabuba et al., 2017).
Measures
Cognitive functioning. Cognitive functioning was measured
using an NP test battery that measures cognition across the seven
ability domains that have been identified as frequently affected in
HIV-associated neurocognitive disorders (Antinori et al., 2007):
Executive functioning (Stroop Color–Word Interference trial, Cat-
egory Test errors, WI Card Sorting Test–64 total errors, and Color
Trails 2), working memory/attention (Paced Auditory Serial Ad-
dition Test–50 and Wechsler Memory Scale-III Spatial Span Test),
speed of information processing (Wechsler Adult Intelligence
Scale-III [WAIS-III], Digit Symbol, WAIS-III Symbol Search,
Trails A, Color Trails 1, Stroop Color Naming and Stroop Word
Naming), verbal fluency (letter fluency, animal fluency, and action
fluency), learning (Hopkins Verbal Learning Test—Revised)
[HVLT-R] and Brief Visuospatial Learning Test—Revised)
[BVMT-R], delayed recall (HVLT-R delay and BVMT-R delay),
and complex motor function (grooved pegboard [dominant and
nondominant hands]). The test battery is appropriate for the current
study because it measures the domains typically affected by HIV.
It is also an internationally well-recognized NP assessment tool
that has been translated into multiple languages around the world
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(Heaton et al., 2010; Heaton, Marcotte, et al., 2004; Hestad et al.,
2012; Kabuba et al., 2011; Kanmogne et al., 2010). The battery has
been previously adapted and normed for the Zambian population
(Hestad et al., 2012).
Test items such as those on the HVLT-R were adapted to make
them more culturally appropriate for Zambia (Hestad et al., 2012).
Age in the current study was a continuous variable, illustrated as
lower and upper quartiles distributions of the data: “young” for
ages 35 years and below, and “old” for ages 47 years and above.
Education was a continuous variable, illustrated as a lower and
upper quartile distribution of the data; less than 9 years of educa-
tion were considered in the category of “low education level,”
while those with 12 years and more in the category of “high
education.”
Disease characteristics. Participants were categorized ac-
cording to whether their HIV viral loads were detectable or unde-
tectable. Viral load was detected at 50 copies/mL. This informa-
tion is considered here because previous studies have reported HIV
viral load detectability as an induction of effective therapy (Ellis et
al., 1997; McArthur et al., 1997).
Nadir CD4 was taken at the point of the participant’s eligibility
for ART and current CD4 taken at the time of data collection for
the current study. Information on duration of ART was obtained
from the patients’ medical files.
AIDS status constituted participants with AIDS and those with-
out AIDS; this information was obtained from the participants’
medical files. In Zambia, AIDS is typically diagnosed when an
HIV-infected individual has a CD4 count below 200 cells/mm3 of
blood, weakening the immune system and putting the individual at
risk of illnesses and infections that are AIDS defining according to
the World Health Organization (WHO) stages (WHO Stages 3 and
4 condition; Childs et al., 1999; Zambia Ministry of Health, 2010).
Nutritional information indexed by body mass index (BMI) was
collected because it has been linked to NP functioning (Joska et al.,
2011).
Ethical Consideration
The study was approved by the University of Zambia Biomed-
ical Research Ethics Committee and Ministry of Health. The
research protocol was also formally approved by the Lusaka Dis-
trict Health Management Team, which oversees the clinics in
Lusaka and the Ministry of Health.
Written informed consent was obtained from all research par-
ticipants. Participants were given the opportunity to take breaks or
withdraw from the study at any time with no penalty incurred. All
the data remained anonymous; the participants were assigned an
arbitrary code for analysis purposes.
Data Management
The raw data obtained on the NP test battery was converted into
demographically corrected T scores based on data previously col-
lected from 324 healthy Zambians (Hestad et al., 2016). The 324
healthy sample comprised 157 (48.5%) males and 167 (51.5%)
females, with an average age of 38.5 (SD  12.80) years and an
average education level of 11.0 (SD  2.58) years. The norming
process was similar to that used for the United States normative
data (Heaton, Miller, et al., 2004). The raw scores were corrected
for the effects of age, education, sex, and urban/rural background
by first converting them to normally distributed scaled scores with
a mean of 10 and SD of 3; the scaled scores were then converted
to demographically corrected T scores with a mean of 50 and SD
of 10. Detailed procedures and results of the norming study have
been reported elsewhere (Hestad et al., 2016).
Global deficit scores were used to determine the neurocognitive
impairment status and impairment levels of the participants
(Blackstone et al., 2012). Global deficit score is a mean of impair-
ment ratings that uses demographically corrected T scores on a
5-point scale from 0 (normal/0 deficits) to 5 (severely impaired). A
deficit score of 0 means normal performance (T score 40),
whereas a deficit score of 1 means mild impairment (T score 
35–39), 2 means mild-to-moderate impairment (T score 30–34),
3 means moderate impairment (T score  25–29), 4 means
moderate-to-severe impairment (T score  20–24), and 5 means
severe impairment (T score 20). Participants were classified as
impaired in an ability domain if they had an average deficit
score 0.5 on that particular cognitive domain. This average is
called the domain deficit score. Participants were further classified
as having global impairment if they had a total average deficit
score 0.5 across all domains (Blackstone et al., 2012; Carey et
al., 2004; Hinkin et al., 2004).
The use of the deficit score approach reflects our focus on
abilities that may have been affected by central nervous system
injury or disease. It has been used in many previous studies of
HIV-associated neurocognitive disorders and, similar to clinical
ratings of NP results (which does not allow for good/normal
performances on some tests or domains obscure problematic re-
sults on others), purposely gives less weight to high test scores in
the normal range (Blackstone et al., 2012).
Statistical Analysis
Descriptive statistics are reported as means and SDs or frequen-
cies. We carried out regression analyses with the following depen-
dent variables, one at a time: NP test performance measured in
seven domains with results presented as T scores and domain and
global deficit scores. In these analyses, years of education, age,
and their interaction were included as continuous covariates. Re-
sults are presented as estimated means with associated standard
errors for ages 35 and 47 years (lower and upper quartile in our
data set), and for 9 years and 12 years of education years, which
are the education levels at which major examinations are taken in
Zambia to qualify for high school and tertiary education, respec-
tively (UNESCO, 2011). This approach uses all the available data,
focuses on conceptually relevant age and education contrasts, and
allows for testing significant effects for age, education, and their
interaction. Also, these education lengths are the lower and upper
quartile in our data set. Education and age were analyzed as
continuous covariates in the current study instead of dichotomizing
these for two main reasons: first, dichotomizing implicitly means
that the effect is assumed constant within each side of the cutpoint,
and makes a discrete “jump” at the cutpoint. This is practically
never realistic. Second, dichotomizing implies loss of statistical
power compared with using the variable as it is.
Here, p values 0.05 are considered significant. However, due
to multiple hypotheses, p values between 0.01 and 0.05 should be
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522 KABUBA ET AL.
interpreted with caution. Analyses were carried out in SPSS Ver-
sion 22.
Results
Demographics and Disease Characteristics
Demographics and disease characteristics are shown in Table 1.
The HIV sample (n  286) had a mean age of 41.35 (SD 
8.56), and a mean number of years of education of 10.16 (SD 
2.18). There were 37.1% males and 62.9% females. In our sample,
56 persons (19.6%) had less than 9 years of education, 128
(44.8%) had 9 to 11 years, and 102 (35.7%) had 12 or more years
of education.
The “normal” effects of age, education, and sex on the NP test
performance were controlled for by using demographically cor-
rected standard scores (T scores) generated with a previously
collected normative sample of 324 HIV-negative participants
(Hestad et al., 2016).
Table 2 shows the estimated means of NP performance across
the seven domains using T score means, Results are illustrated for
the lower and upper quartiles of age and education: for younger
and older age levels estimated for ages 35 and 47 years, respec-
tively, and for low and high education levels, 9 and 12 years of
education, respectively. In these analyses, years of education, age,
and their interaction were included as continuous covariates.
As seen in the table, there is a statistically significant effect of
age and/or education for learning, recall, and motor functions. This
is illustrated in Figure 1. In what follows, we report p values for
age and education for these.
For learning, young but not old age had a significant (p  .003)
effect of education, with higher education showing relatively pre-
served/normal abilities. There is only a negligible and nonsignif-
icant effect of education.
For recall, at the young age there is again a significant (p 
.026) effect of education, with low education being associated with
poorer performance. At an older age level, again higher education
was marginally with better performance associated with higher
education.
For motor functions, all mean estimated scores were high and
normal, regardless of age and education with lower education
actually being associated with better motor performance.
To further investigate the effects of age and education on NP
performance across the seven domains, we conducted analyses
adjusted for the following potential confounders simultaneously:
nadir CD4, current CD4, AIDS status, duration on ART, viral load
detection, BMI, and gender. These results remained substantially
the same when adjusting for the potential confounders; data not
shown.
Table 3 shows the estimated means of NP deficit scores across
the seven domains and globally for ages 35 and 47, and 9 and 12
years of education. In these analyses, years of education, age, and
their interaction were included as continuous covariates.
As seen in the table, there is a statistically significant effect of
age and/or education for learning, executive function, motor func-
tions, and the global deficit score and a trend for processing speed.
This is illustrated in Figure 2. Although the overall model for
motor functions was statistically significant, age and education on
their own had no statistically significant effect in this domain. In
what follows, we report p values for age and education for these.
For learning, young but not old age had a significant (p  .01)
effect on education. The younger, less educated had poorer per-
formance compared with the younger, more educated group.
For executive functions, at the younger age level there is a
significant (p  .05) effect of education. The younger, less edu-
cated had poorer performance compared with the younger, more
educated group. At the older age there is only a negligible and
nonsignificant effect of less age or less education.
For speed of information processing, the younger, less educated
had poorer performance (p  .03) compared with the younger,
more educated group. The older age groups showed nonsignificant
effects of both age and education.
For global deficit scores, the young age and less educated group
had poorer performance (p  .03) compared with the younger
more educated group. The older age group exhibited negligible and
nonsignificant effect of age and education effects.
To further investigate the effects of age and education on NP
performance across the seven domains, we conducted analyses
adjusted for the following potential confounders’ simultaneously:
nadir CD4, current CD4, AIDS status, duration on ART, viral load
detection, BMI, and gender. The results remained substantially the
same when adjusting for the potential confounders; data not
shown.
Table 1
Demographic and Disease/Treatment Characteristics of HIV Sample
Demographic and disease characteristics N Mean/percentage SD
Age 286 41.35 8.56
Education 286 10.16 2.18
Female gender 286 62.9%
Nadir CD4 207 212.89 156.31
Current CD4 261 515.04 255.89
Undetectable viral load 261 78.3%
Duration on ART 198 57.57 30.83
With AIDS 224 37.4%
BMI 188 23.48 5.01
Note. The sample sizes (n) for disease characteristics vary due to missing data. Neuropsychological perfor-
mance based on age and education in the HIV sample. ART antiretroviral therapy; BMI body mass index.
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Discussion
Age and Neurocognitive Functioning in the
HIV Sample
We hypothesized that the older HIV participants would have
poorer cognitive performance on the NP tests compared with the
younger HIV participants. Advancing age is typically reported to
be associated with a decline in cognitive functioning (Hardy &
Vance, 2009; Kissel, Pukay-Martin, & Bornstein, 2005; Milanini
& Valcour, 2017; Vance, 2009; Vance et al., 2014). In the current
study, the effects of normal aging and education levels in healthy
individuals were controlled by the use of demographically cor-
rected NP test norms. Thus our explanation was that HIV infection
would exacerbate the process of normal cognitive aging.
Contrary our hypothesis, advancing age in our HIV sample
did not negatively affect cognitive performance on the NP tests.
The statistically significant effect of age yielded from the current
study showed that the younger HIV group with less education
performed worse on learning and recall on the mean T scores than
the younger HIV group with more education. A similar trend
was observed on the impairment scores in which the younger, less
educated performed more poorly on the learning domain scores
and global deficit scores than the younger, more educated group.
The results obtained in the current study are counterintuitive
although similar to those reported by Wilkie et al., 2003, who
reported that certain cognitive processes may be more impaired in
the younger than the older HIV-1 infected adults. They reported
that learning and delayed recall were more impaired in the younger
HIV compared with the older HIV group. Caveat the NP
performance differences observed in the current study we assume,
were not due to age effects but rather due to education effects/
cognitive reserve. Although the current study findings may appear
to be counterintuitive, we postulates that, age effects (young vs.
old) were likely masked because the sample in the current study
was relatively young compared with the previous studies that
reveal that individuals over the age of 60 typically demonstrate
negative cognitive results owing to age on NP evaluation (Ardila,
1998; Becker, Lopez, Dew, & Aizenstein, 2004; De Ronchi et al.,
2002; Milanini & Valcour, 2017; Wilkie et al., 2003).
On the contrary, similar to the current study findings, previous
studies have indicated that there is a minimal interference and
sometimes no evidence of age and HIV infection on neurocogni-
Table 2
Estimated Mean of NP Performance From Linear Regression With Age, Education, and Their Interaction as Continuous Covariates
(Mean T Scores)
Age 35 years Age 47 years
p valueDomain
9 years edu.
EM (SE)
12 years edu.
EM (SE)
9 years edu.
EM (SE)
12 years edu.
EM (SE)
Executive 46.05 (.56) 47.38 (.66) 47.11 (.53) 47.23 (.57) .211
Fluency 46.39 (.65) 46.59 (.76) 47.53 (.61) 47.12 (.65) .483
Working memory 44.80 (.72) 44.09 (.84) 45.46 (.68) 44.68 (.73) .580
Learning 43.05 (.66) 45.59 (.77) 45.60 (.62) 45.76 (.66) .002
Recall 44.02 (.69) 46.02 (.80) 45.99 (.65) 47.00 (.69) .014
Motor 54.04 (.90) 51.69 (1.05) 52.05 (.85) 49.86 (.91) .008
Speed of information processing 45.83 (.67) 46.53 (.72) 47.17 (.58) 46.81 (.62) .292
Global mean T 46.18 (.48) 46.80 (.56) 47.27 (.45) 46.98 (.48) .249
Note. p value for the combined effect of these covariates (F test with 3 degrees of freedom). Bold values are meant to highlight the statistically significant
results. Results are presented as estimated means with associated standard errors for ages 35 and 47 years (lower and upper quartile in our data set), and
for 9 years and 12 years of education years. See the online supplemental materials for tables showing beta estimates and confidence intervals. NP 
neuropsychological; EM  estimated mean; SE  standard error.
Figure 1. Estimated mean T scores for learning, recall, and motor functions, from linear regression with age,
education, and their interaction as covariates. See the online article for the color version of this figure.
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tive functions (Hardy et al., 1999; Van Gorp et al., 1994; Wilkie et
al., 2003).
Education and Neurocognitive Functioning in the
HIV Sample
We had postulated that within the context of HIV infection,
participants with higher levels of education would show less
cognitive impairment than those with lower levels of education.
This was confirmed in the current study but only at the lower age
range (see Tables 2 and 3). The younger and less educated in the
current study were found to perform more poorly on learning,
executive function, processing speed, and on the global deficit
scores. The results yielded in the present study are in agreement
with previous studies (Satz et al., 1993; De Ronchi et al., 2002),
which show that level of education has an effect on cognitive
functioning in the HIV. This result shows that the effect of
cognitive reserve was more apparent in the young age level than in
Table 3
Estimated Mean of NP Deficit Scores From Linear Regression With Age, Education, and Their Interaction as Continuous Covariates
(Domain Deficit Scores)
Age 35 years Age 47 years
p valueDomain
9 years edu.
EM (SE)
12 years edu.
EM (SE)
9 years edu.
EM (SE)
12 years edu.
EM (SE)
Executive .44 (.04) .28 (.05) .36 (.04) .34 (.04) .032
Fluency .52 (.06) .45 (.07) .43 (.05) .44 (.06) .589
Working memory .67 (.07) .59 (.08) .60 (.07) .63 (.07) .679
Learning .66 (.06) .46 (.07) .40 (.06) .46 (.06) .001
Recall .56 (.06) .43 (.07) .46 (.06) .37 (.06) .133
Motor .14 (.05) .17 (.06) .25 (.05) .35 (.05) .009
Speed of information processing .49 (.05) .39 (.06) .37 (.05) .43 (.05) .056
Global deficit score .49 (.04) .39 (.04) .40 (.04) .43 (.04) .035
Note. p value for the combined effect of these covariates (F test with 3 degrees of freedom). Bold entries meant to highlight the statistically significant
results. Results are presented as estimated means with associated standard errors for ages 35 and 47 years (lower and upper quartile in our data set), and
for 9 years and 12 years of education years. See the online supplemental materials for tables showing beta estimates and confidence intervals. NP 
neuropsychological; EM  estimated mean; SE  standard error.
Figure 2. Estimated mean deficit scores for executive functions domain deficit score (DDS), Learning DDS,
global deficit scores and speed of information processing DDS from linear regression with age, education and
their interaction as covariates. See the online article for the color version of this figure.
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the older age level participants with more years of education.
Previous studies have shown that due to cognitive reserve, higher
education groups tend to have a slower decline on cognitive tests
than those with lower educational levels (Ardila, 1998; Ardila et
al., 2000; Bornstein & Suga, 1988; Le Carret et al., 2003; Lezak,
1995; Ostrosky-Solis et al., 1998; Stern, 2002; Tombaugh, 2004;
Welch et al., 1996).
In addition, the current study yielded peculiar results regarding
education and performance on motor functions. Interestingly, al-
though the scores for all age and education groups regarding motor
functions were within the normal range; the older, more educated
group did not perform as well as the less educated, younger group.
This result is consistent with results obtained by Robertson et al.
(2007) in Uganda and Heaton et al. (2011), who report that
grooved pegboard tasks were less affected in the HIV in Com-
bination antiretroviral therapy (CART) era. This result could be an
indication that motor functions are not adversely affected in HIV
individuals on ART in Zambia.
On the contrary, this result could possibly be an indicator that
the younger sample with less education might be more involved in
manual work that demands motor dexterity as opposed to the older
sample. Presumably, since the older participants in the current
study are engaged in cognitively demanding jobs, their perfor-
mance on neuropsychology tests is better and more homogeneous
due to the positive neuroplasticity resulting from the cognitively
demanding tasks they perform. Furthermore, the assumption
would be that the younger group in our sample is presumably
engaged in different work conditions where the younger, less
educated are involved in manual work and the younger, more
educated in cognitively demanding jobs, which could account for
the differences observed between the two groups. The younger,
more educated benefit from the cognitive reserve as a result of
education and continued use of cognitive skills and thus perform
better on the NP tests (Mahncke, Bronstone, & Merzenich, 2006;
Vance & Burrage, 2006).
The implication of this is that cognitive performance is worse
for HIV people who are younger and less educated in Zambia.
There is, however, a need to carry out further research to ascertain
why this could be the case. It could also be necessary to carry out
a longitudinal study that would better take into account the differ-
ences that could account for the effects of age and education on
neurocognitive impairment in HIV adults in Zambia.
Conclusion
The findings obtained from the current study show that there
was an effect of level of education on neurocognition in the HIV
younger sample. The cognitive reserve properties associated with
higher education enabled the younger, more educated participants
to perform better than the younger, less educated group on neuro-
cognitive tests. The current study also revealed that motor func-
tions are preserved in the HIV on CART in Zambia. This could
be an indication that the younger, less educated need to be em-
powered in disease management.
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